Great Point Partners LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Great Point Partners LLC disclosed 29 US equity positions worth $331.4m in its Q3 2024 13F filing. The largest position was NGNE at 12.7% of the reported book, followed by ABVX and PLRX.
What did Great Point Partners LLC own in Q3 2024? Top 29 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | NGNE NEUROGENE INC | 12.7% | $42.1m | 1,004,291 | – | ||
| 2 | ABVX ABIVAX SA | 7.4% | $24.5m | 2,128,773 | – | ||
| 3 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 6.5% | $21.4m | 1,910,121 | – | |
| 4 | EOLS EVOLUS INC | Healthcare | 5.7% | $19.0m | 1,170,000 | – | |
| 5 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 5.1% | $17.1m | 750,000 | – | |
| 6 | CYTK CYTOKINETICS INC | Healthcare | 5.0% | $16.7m | 316,000 | – | |
| 7 | 4XC1 KALVISTA PHARMACEUTICALS INC | 4.5% | $15.0m | 1,299,503 | – | ||
| 8 | DVAX DYNAVAX TECHNOLOGIES CORP | 4.5% | $14.8m | 1,326,234 | – | ||
| 9 | CNTX CONTEXT THERAPEUTICS INC | 4.1% | $13.6m | 6,934,982 | – | ||
| 10 | ZURA ZURA BIO LTD | Healthcare | 4.0% | $13.3m | 3,263,672 | – | |
| 11 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 3.8% | $12.6m | 514,659 | – | |
| 12 | MERUS N V | 3.8% | $12.5m | 250,000 | – | ||
| 13 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 3.6% | $11.9m | 1,000,000 | – | |
| 14 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 3.1% | $10.2m | 255,000 | – | |
| 15 | AUTL AUTOLUS THERAPEUTICS PLC | Healthcare | 3.1% | $10.2m | 2,811,955 | – | |
| 16 | URGN UROGEN PHARMA LTD | Healthcare | 2.9% | $9.6m | 758,786 | – | |
| 17 | OPTINOSE INC | 2.6% | $8.6m | 12,861,136 | – | ||
| 18 | ACLXGBX ARCELLX INC | 2.5% | $8.4m | 100,000 | – | ||
| 19 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 2.3% | $7.5m | 275,000 | – | |
| 20 | OTLK OUTLOOK THERAPEUTICS INC | 2.1% | $6.9m | 1,293,028 | – | ||
| 21 | JSPR JASPER THERAPEUTICS INC | 1.8% | $6.1m | 322,380 | – | ||
| 22 | VYGR VOYAGER THERAPEUTICS INC | Healthcare | 1.7% | $5.6m | 959,953 | – | |
| 23 | HELIX ACQUISITION CORP II | 1.6% | $5.2m | 500,000 | – | ||
| 24 | TCRX TSCAN THERAPEUTICS INC | 1.5% | $5.1m | 1,016,375 | – | ||
| 25 | UNCY UNICYCIVE THERAPEUTICS INC | 1.1% | $3.5m | 8,559,000 | – | ||
| 26 | PROMIS NEUROSCIENCES INC | 1.1% | $3.5m | 2,790,698 | – | ||
| 27 | RNAC CARTESIAN THERAPEUTICS INC | 1.0% | $3.2m | 200,000 | – | ||
| 28 | VTGN VISTAGEN THERAPEUTICS INC | 0.6% | $2.0m | 674,075 | – | ||
| 29 | CLYM ELIEM THERAPEUTICS INC | 0.4% | $1.3m | 248,168 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.